Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 111(17): E1768-76, 2014 Apr 29.
Artigo em Inglês | MEDLINE | ID: mdl-24733896

RESUMO

We sequenced the genomes of 3,615 strains of serotype Emm protein 1 (M1) group A Streptococcus to unravel the nature and timing of molecular events contributing to the emergence, dissemination, and genetic diversification of an unusually virulent clone that now causes epidemic human infections worldwide. We discovered that the contemporary epidemic clone emerged in stepwise fashion from a precursor cell that first contained the phage encoding an extracellular DNase virulence factor (streptococcal DNase D2, SdaD2) and subsequently acquired the phage encoding the SpeA1 variant of the streptococcal pyrogenic exotoxin A superantigen. The SpeA2 toxin variant evolved from SpeA1 by a single-nucleotide change in the M1 progenitor strain before acquisition by horizontal gene transfer of a large chromosomal region encoding secreted toxins NAD(+)-glycohydrolase and streptolysin O. Acquisition of this 36-kb region in the early 1980s into just one cell containing the phage-encoded sdaD2 and speA2 genes was the final major molecular event preceding the emergence and rapid intercontinental spread of the contemporary epidemic clone. Thus, we resolve a decades-old controversy about the type and sequence of genomic alterations that produced this explosive epidemic. Analysis of comprehensive, population-based contemporary invasive strains from seven countries identified strong patterns of temporal population structure. Compared with a preepidemic reference strain, the contemporary clone is significantly more virulent in nonhuman primate models of pharyngitis and necrotizing fasciitis. A key finding is that the molecular evolutionary events transpiring in just one bacterial cell ultimately have produced millions of human infections worldwide.


Assuntos
Epidemias , Evolução Molecular , Genoma Bacteriano/genética , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/genética , Streptococcus pyogenes/genética , Streptococcus pyogenes/patogenicidade , Animais , Sequência de Bases , Modelos Animais de Doenças , Fasciite Necrosante/epidemiologia , Fasciite Necrosante/genética , Fasciite Necrosante/microbiologia , Finlândia/epidemiologia , Genes Bacterianos/genética , Genômica , Humanos , Mutação INDEL/genética , Faringite/epidemiologia , Faringite/genética , Faringite/microbiologia , Polimorfismo de Nucleotídeo Único/genética , Primatas/microbiologia , Seleção Genética , Sorotipagem , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes/isolamento & purificação , Fatores de Tempo , Virulência/genética
2.
Infect Immun ; 82(4): 1600-5, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24452687

RESUMO

Staphylococcus aureus small-colony variants (SCVs) are implicated in chronic and relapsing infections that are difficult to diagnose and treat. Despite many years of study, the underlying molecular mechanisms and virulence effect of the small-colony phenotype remain incompletely understood. We sequenced the genomes of five S. aureus SCV strains recovered from human patients and discovered previously unidentified nonsynonymous point mutations in three genes encoding proteins in the menadione biosynthesis pathway. Analysis of genetic revertants and complementation with wild-type alleles confirmed that these mutations caused the SCV phenotype and decreased virulence for mice.


Assuntos
Mutação Puntual , Polimorfismo de Nucleotídeo Único , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/genética , Vitamina K 3 , Animais , Antibacterianos/farmacologia , Modelos Animais de Doenças , Genoma Bacteriano , Gentamicinas/farmacologia , Camundongos , Testes de Sensibilidade Microbiana , Fenótipo , Análise de Sequência de DNA , Infecções Estafilocócicas/genética , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/metabolismo , Staphylococcus aureus/patogenicidade , Virulência/genética , Vitamina K 3/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA